187 related articles for article (PubMed ID: 33588452)
1. Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?
De Marchis GM
Hamostaseologie; 2021 Feb; 41(1):31-34. PubMed ID: 33588452
[TBL] [Abstract][Full Text] [Related]
2. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
3. Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.
Meinel TR; Branca M; De Marchis GM; Nedeltchev K; Kahles T; Bonati L; Arnold M; Heldner MR; Jung S; Carrera E; Dirren E; Michel P; Strambo D; Cereda CW; Bianco G; Kägi G; Vehoff J; Katan M; Bolognese M; Backhaus R; Salmen S; Albert S; Medlin F; Berger C; Schelosky L; Renaud S; Niederhauser J; Bonvin C; Schaerer M; Mono ML; Rodic B; Tarnutzer AA; Mordasini P; Gralla J; Kaesmacher J; Engelter S; Fischer U; Seiffge DJ;
Ann Neurol; 2021 Jan; 89(1):42-53. PubMed ID: 32996627
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
5. Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis.
De Marchis GM; Seiffge DJ; Schaedelin S; Wilson D; Caso V; Acciarresi M; Tsivgoulis G; Koga M; Yoshimura S; Toyoda K; Cappellari M; Bonetti B; Macha K; Kallmünzer B; Cereda CW; Lyrer P; Bonati LH; Paciaroni M; Engelter ST; Werring DJ
J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):119-125. PubMed ID: 34635567
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
[TBL] [Abstract][Full Text] [Related]
7. The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation.
van den Dries CJ; van Doorn S; Souverein P; Pajouheshnia R; Moons KGM; Hoes AW; Geersing GJ; van den Ham HA
TH Open; 2020 Oct; 4(4):e417-e426. PubMed ID: 33376941
[No Abstract] [Full Text] [Related]
8. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.
Hoolwerf EW; Kraaijpoel N; Büller HR; van Es N
Thromb Res; 2018 Oct; 170():102-108. PubMed ID: 30153564
[TBL] [Abstract][Full Text] [Related]
9. Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation - K-PLUS registry.
Nakajima M; Inatomi Y; Ueda A; Ito Y; Kouzaki Y; Takita T; Wada K; Yonehara T; Terasaki T; Hashimoto Y; Ando Y
J Clin Neurosci; 2021 Jul; 89():106-112. PubMed ID: 34119252
[TBL] [Abstract][Full Text] [Related]
10. Timing of Anticoagulation after Acute Ischemic Stroke in Patients with Atrial Fibrillation.
Alrohimi A; Jickling G; Buck B; Butcher KS
Can J Neurol Sci; 2023 Jul; 50(4):503-514. PubMed ID: 35762354
[TBL] [Abstract][Full Text] [Related]
11. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
[TBL] [Abstract][Full Text] [Related]
12. Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study.
Paschke LM; Klimke K; Altiner A; von Stillfried D; Schulz M
BMC Med; 2020 Aug; 18(1):254. PubMed ID: 32847578
[TBL] [Abstract][Full Text] [Related]
13. No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
Zweiker D; Manninger M; Sieghartsleitner R; Ebner J; Pratl B; Bisping E; Lercher P; von Lewinski D; Riedlbauer R; Rohrer U; Spronk HMH; Zirlik A; Schotten U; Scherr D
Int J Cardiol; 2021 May; 331():106-108. PubMed ID: 33508338
[TBL] [Abstract][Full Text] [Related]
14. Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke-A case control study.
Rekk K; Arnet I; Dietrich F; Polymeris AA; Lyrer PA; Engelter ST; Schaedelin S; Allemann SS
PLoS One; 2024; 19(4):e0301421. PubMed ID: 38662779
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.
Seiffge DJ; Paciaroni M; Wilson D; Koga M; Macha K; Cappellari M; Schaedelin S; Shakeshaft C; Takagi M; Tsivgoulis G; Bonetti B; Kallmünzer B; Arihiro S; Alberti A; Polymeris AA; Ambler G; Yoshimura S; Venti M; Bonati LH; Muir KW; Yamagami H; Thilemann S; Altavilla R; Peters N; Inoue M; Bobinger T; Agnelli G; Brown MM; Sato S; Acciarresi M; Jager HR; Bovi P; Schwab S; Lyrer P; Caso V; Toyoda K; Werring DJ; Engelter ST; De Marchis GM;
Ann Neurol; 2019 Jun; 85(6):823-834. PubMed ID: 30980560
[TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
18. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists.
Daher J; Da Costa A; Hilaire C; Ferreira T; Pierrard R; Guichard JB; Romeyer C; Isaaz K
Clin Drug Investig; 2020 Apr; 40(4):343-353. PubMed ID: 32144651
[TBL] [Abstract][Full Text] [Related]
19. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
Alcocer L
Am J Cardiovasc Drugs; 2016 Jun; 16(3):171-82. PubMed ID: 26923792
[TBL] [Abstract][Full Text] [Related]
20. Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants.
Stolk LM; de Vries F; Ebbelaar C; de Boer A; Schalekamp T; Souverein P; Ten Cate-Hoek A; Burden AM
Br J Clin Pharmacol; 2017 Aug; 83(8):1835-1843. PubMed ID: 28326589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
